Aquestive Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$12,807
$10,003
$8,720
$11,867
Gross Profit
8,301
5,442
5,068
7,347
EBITDA
-11,034
-9,132
-15,763
-12,698
EBIT
-11,173
-9,272
-18,652
-12,845
Net Income
-15,446
-13,548
-22,930
-17,055
Net Change In Cash
12,807
10,003
8,720
11,867
Free Cash Flow
-12,884
-8,021
-23,535
-6,504
Cash
129,062
60,536
68,657
71,546
Basic Shares
110,584
99,326
95,497
91,199

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$57,561
$50,583
$47,680
$50,832
Gross Profit
39,689
29,752
28,294
35,843
EBITDA
-26,616
1,182
-39,580
-45,114
EBIT
-27,334
-163
-41,967
-48,078
Net Income
-44,137
-7,870
-54,410
-70,539
Net Change In Cash
57,561
50,583
47,680
50,832
Cost of Revenue
-3,783
Free Cash Flow
-35,918
-7,375
-12,313
-33,892
Cash
71,546
23,872
27,273
28,024
Basic Shares
86,726
61,255
48,734
38,077

Earnings Calls

QuarterEPS
2025-09-30
-$0.11
2025-06-30
-$0.14
2025-03-31
-$0.22
2024-12-31
-$0.16